FAPI PET/MRI imaging for breast cancer
Part of Cancer clinical trials.
This trial tests a new imaging method (FAPI PET/MRI) to see if it can help evaluate breast cancer. It focuses on people with invasive breast cancer who are about to start treatment before surgery or who have recurrent or new breast cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with invasive breast cancer that has spread locally.
- You are scheduled to have neoadjuvant therapy (treatment before surgery) as your main treatment, or you have breast cancer that came back or is new.
- You may also qualify if you are getting neoadjuvant therapy and having a type of PET/CT scan called FDG-PET/CT for staging.
- You must not have any other type of cancer besides breast cancer.
- You must not have kidney problems or an allergy to contrast dyes used in imaging.
- You must not have any implants that are unsafe for MRI (like certain metal devices).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.
This study tests a new type of PET scan that uses a special tracer called FAPI to find where cancer has spread in your body. It may help doctors see hidden tumors more clearly without needing extra treatments first.
This trial studies a special PET/CT scan called FAPI PET/CT to see how well it can detect or track cancerous tumors. It may help doctors better understand your cancer without extra procedures.
This trial uses a special PET scan (68Ga-FAPi-46) to see how breast cancer interacts with nearby cells. It may help doctors understand your tumor better and guide treatment decisions, especially if you are planning surgery or chemotherapy before surgery.
This study uses a special type of PET scan called FAPI PET to see if it can help detect or monitor cancer and other diseases. It is for people who already need a PET or CT/MRI scan as part of their standard care.
This study tests how useful a special PET/CT scan (called 68Ga-FAPI) is for people who may have or have been diagnosed with cancer. The scan may help doctors see cancer activity more clearly.
Hear when a new Breast Neoplasm Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.